期刊文献+

孕激素保守疗法治疗早期子宫内膜癌的疗效及对患者血清肿瘤标志物的影响 被引量:12

The effect of progesterone conservative therapy in the treatment of early stage endometrial cancer and its influence on serum tumor markers
下载PDF
导出
摘要 目的探讨孕激素保守疗法治疗早期子宫内膜癌中的应用价值,并观察其对患者血清肿瘤标志物甲壳质酶蛋白40(YKL-40)、鳞状细胞癌抗原(SCCAg)、细胞角蛋白21-1片段(CYFRA21-1)及血清炎性因子超敏-C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)、白细胞介素4(IL-4)水平的影响。方法选择早期子宫内膜癌患者96例,随机分为对照组(n=48)与研究组(n=48)。对照组患者给予刮宫手术治疗,研究组采用孕激素保守疗法治疗。采用酶联免疫吸附法(ELISA)测定并比较两组血清YKL-40、SCCAg、CYFRA21-1及hs-CRP、TNF-α、IL-4水平,观察两组治疗效果。结果治疗前,两组血清YKL-40、SCCAg、CYFRA21-1肿瘤标志物水平之间无显著差异(P>0.05);治疗后,研究组血清YKL-40、SCCAg、CYFRA21-1肿瘤标志物水平均显著低于对照组(P<0.05)。治疗前,两组血清hs-CRP、TNF-α、IL-4炎性因子水平之间无显著差异(P>0.05);治疗后,研究组血清hs-CRP、TNF-α、IL-4炎性因子水平均显著低于对照组(P<0.05)。研究组治疗总有效率为93.75%,显著高于对照组治疗总有效率68.75%(P<0.05)。研究组完全缓解患者复发率为6.25%,对照组完全缓解患者复发率为29.17%,两组比较差异有统计学意义(P<0.05)。结论与刮宫手术比较,早期子宫内膜癌患者实施孕激素保守疗法治疗的效果较佳,能够有效降低患者血清YKL-40、SCCAg、CYFRA21-1及hs-CRP、TNF-α、IL-4水平,降低患者的复发率,值得应用。 ObjectiveTo explore the application value of progesterone conservative therapy early in endometrial carcinoma,and observe the effect on serum tumor markers of chitinase protein40(YKL-40),squamous cell carcinoma antigen(SCCAg),cytokeratin fragment21-1(CYFRA21-1)and serum inflammatory factor high-sensitivity-C reactive protein(hs-CRP)tumor necrosis factor alpha(TNF-α),interleukin4(IL-4)level of influence.Methods96cases of patients with early endometrial cancer were randomly divided into control group(n=48)and study group(n=48).The control group were treated with curettage surgery treatment,the study group with progesterone conservative therapy.Serum YKL-40,SCCAg,CYFRA21-1,TNF-α,IL-4and HsCRP alpha were acquired with the ELISA method,to observe the therapeutic effect of two groups.ResultsBefore treatment,serum YKL-40,SCCAg and CYFRA21-1levels of tumor markers between two groups had no significant difference(P>0.05).serum YKL-40,SCCAg,CYFRA21-1of tumor markers in water in the study group after treatment were obviously lower than control group(P<0.05).Before treatment,no significant difference of serum hs-CRP,TNF-alpha,IL-4levels of inflammatory cytokines between the two groups were found(P>0.05).Serum hs-CRP,TNF-α,IL-4inflammatory factor levels in the study group after treatment were significantly lower than those in the control group(P<0.05).The total effective rate of the treatment group was93.75%,which was significantly higher than that of the control group(P<0.05).The total effective rate of the treatment group was significantly higher than that of the control group(P<0.05).The recurrence rate of the patients in the study group was6.25%,and the recurrence rate of the patients in the control group was significantly higher than that of the control group(P<0.05).The difference was statistically significant between the two groups.ConclusionCompared with curettage surgery,progesterone conservative treatment in early endometrial cancer patients is better,it can effectively reduce the serum levels of YKL-40,SCCAg,CYFRA21-1and hs-CRP,TNF-alpha,IL-4levels,reduce the recurrence rate,worthy of application.
作者 李婵玉 邓洁 徐蕾 罗剑波 邓晓杨 LI Chan-yu;DENG Jie;XU Lei(Department Obstetrics and Gynecology, The First Affiliated Hospital of Chengdu Medical College, Chengdu Sichuan 610500, China.)
出处 《临床和实验医学杂志》 2017年第23期2361-2364,共4页 Journal of Clinical and Experimental Medicine
关键词 子宫内膜癌 孕激素保守疗法 刮宫手术 肿瘤标志物 Endometrial carcinoma Progesterone conservative treatment Curettage Serum index
  • 相关文献

参考文献13

二级参考文献164

  • 1王志启,王建六,郭健,魏丽惠.内分泌辅助治疗子宫内膜癌的临床意义[J].中华医学杂志,2005,85(34):2414-2419. 被引量:21
  • 2高敏,魏丽惠,孙蓬明,赵丹,李小平.雌激素受体相关受体α和雌激素受体α在子宫内膜癌中的表达及临床意义[J].北京大学学报(医学版),2006,38(5):463-465. 被引量:14
  • 3PARK H, SEOK J M, YOON B S, et al. Effectiveness of high- dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium [ J ] . Arch Gynecol Obstet, 2012, 285(2): 473-478.
  • 4NEENA P, MICHAEL T, JENNIFER S, et al. Differential Regulation of growth factors and matrix metalloproteinase-1 by estrogen, progesterone, and tamoxifen in normal and cancerous endometrial cells [J]. J Cancer Mol, 2009, 4(6): 169-173.
  • 5YAHATA T, FUJITA K, AOKI Y, et al. Long-term conservative therapy for endometrial adenocarcinoma in young women [ J ]. Hum Reprod, 2006, 21(1): 1070-1075.
  • 6PARK J C, CHO C H, RHEE J H. A successful live birth through in vitro fertilization program after conservative treatment of FIGO grade I endometrial [ J ] . J Korean Med Sci, 2006, 21(1): 567-571.
  • 7NIWA K, TAGAM! K, LIAN Z, et al. Outcome of fertility-- preserving treatment in young women with endometrial carcinomas [ J ] . BJOG, 2005, 1(1): 317-320.
  • 8BORROW C P, BUNDY B N, KU RMAN R J, et al. Relationship between surgical-pathological risk fact ors an d out come in clinical stageⅠ and Ⅱ carcinoma of the endometrium: a Gynecologic Oncology Group study [J]. Gynecol Oneol, 1991, 40(1): 55-65.
  • 9RAMIREZ P T, FRUMOVITZ M, BODURKA D C, et al. Hormonal therapy for the management of grade 1 endometrial adenocareinoma:a literature review. [ J ] . Gynecol Oncol, 2004, 95(1): 133-138.
  • 10CORMIO G, MARTINO R, LOIZZI V, et al. A rare case of ehoroidal metastasis presented after conservative management of endometrial cancer [ J ] . Int J Gynecol Cancer, 2006, 16(1): 2044-2048.

共引文献97

同被引文献99

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部